Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 10 of 10

Full-Text Articles in Medicine and Health Sciences

Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava Sep 2009

Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava

Amresh Srivastava

No abstract provided.


Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava Sep 2009

Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava

Amresh Srivastava

No abstract provided.


Treatment Resistant Depression, Amresh Srivastava Aug 2009

Treatment Resistant Depression, Amresh Srivastava

Amresh Srivastava

No abstract provided.


Treatment Resistant Depression, Amresh Srivastava Aug 2009

Treatment Resistant Depression, Amresh Srivastava

Amresh Srivastava

No abstract provided.


Association Between Serum 25-Hydroxyvitamin D And Depressive Symptoms In Japanese: Analysis By Survey Season, A. Nanri, T. Mizoue, Y. Matsushita, Kalpana Poudel-Tandukar, M. Sato, M. Ohta, N. Mishima Aug 2009

Association Between Serum 25-Hydroxyvitamin D And Depressive Symptoms In Japanese: Analysis By Survey Season, A. Nanri, T. Mizoue, Y. Matsushita, Kalpana Poudel-Tandukar, M. Sato, M. Ohta, N. Mishima

Kalpana Poudel-Tandukar

Both depressive symptoms and vitamin D insufficiency are common during winter. This study examined the association between serum 25-hydroxyvitamin D and depressive symptoms by survey season. Subjects were 527 municipal employees aged 21–67 years of two municipal offices in Japan. Overall, there was no measurable association. However, in the workplace surveyed in November, multivariate-adjusted odds ratios (95% confidence interval) of having depressive symptoms (Center for Epidemiologic Studies Depression score of X16) for the lowest through highest quartiles of serum 25-hydroxyvitamin D were 1.00 (reference), 0.84 (0.45–1.58), 0.83 (0.44–1.58) and 0.59 (0.30–1.15), respectively (trend P ¼ 0.14). The association with the …


Mood Symptoms As Comorbidity In Schizophrenia, Amresh Srivastava Jul 2009

Mood Symptoms As Comorbidity In Schizophrenia, Amresh Srivastava

Amresh Srivastava

No abstract provided.


Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 1), Amresh Srivastava Jul 2009

Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 1), Amresh Srivastava

Amresh Srivastava

No abstract provided.


Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 2), Amresh Srivastava Jul 2009

Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 2), Amresh Srivastava

Amresh Srivastava

No abstract provided.


Self-Criticism Versus Neuroticism In Predicting Depression And Psychosocial Impairment For 4 Years In A Clinical Sample, David M. Dunkley, Charles A. Sanislow, Carlos M. Grilo, Thomas H. Mcglashan Jun 2009

Self-Criticism Versus Neuroticism In Predicting Depression And Psychosocial Impairment For 4 Years In A Clinical Sample, David M. Dunkley, Charles A. Sanislow, Carlos M. Grilo, Thomas H. Mcglashan

Charles A. Sanislow, Ph.D.

The present study extended previous findings demonstrating self-criticism, assessed by the Dysfunctional Attitude Scale (DAS) (Weissman AN, Beck AT. Development and validation of the Dysfunctional Attitude Scale: a preliminary investigation. Paper presented at the 86th Annual Convention of the American Psychological Association, Toronto, Ontario, Canada, 1978), as a potentially important prospective predictor of depressive symptoms and psychosocial functional impairment over time. Using data from a prospective, 4-year study of a clinical sample, DAS self-criticism and neuroticism were associated with self-report depressive symptoms, interviewer-rated major depression, and global domains of psychosocial functional impairment 4 years later. Hierarchical multiple regression results indicated …


'Why I Feel Bad': Refinement On The Effects Of Prostate Cancer Upon Lifestyle Questionnaire And An Initial Exploration Of Its Links With Anxiety And Depression Among Prostate Cancer Patients, Christopher Sharpley, Vicki Bitsika, David Christie Dec 2008

'Why I Feel Bad': Refinement On The Effects Of Prostate Cancer Upon Lifestyle Questionnaire And An Initial Exploration Of Its Links With Anxiety And Depression Among Prostate Cancer Patients, Christopher Sharpley, Vicki Bitsika, David Christie

Vicki Bitsika

Objective: To psychometrically refine a standardized scale for identifying those lifestyle changes that were most likely to contribute to anxiety and depression among prostate cancer (PCa) patients.

Methods: Three hundred and eighty-one PCa patients who had received their initial diagnosis between one and 96 months completed a survey of background variables, anxiety and depression inventories and the 36-item Effects of Prostate Cancer upon Lifestyle Questionnaire (EPCLQ).

Results: Levels of anxiety (24%) and depression (26%) were similar to those previously reported for PCa patients. The EPCLQ was shown to have satisfactory psychometric properties and significantly predicted anxiety and depression scores and …